Bioregenx (BRGX) Current Deferred Revenue (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Current Deferred Revenue of $56528.0 in Q1 2026, down 6.14% quarter-over-quarter from $60227.0 in Q4 2025, and down 70.14% on a YoY basis from $189282.0 in Q1 2025.
Bioregenx (BRGX) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Bioregenx's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $56528.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 70.14% year-over-year to $56528.0; the TTM figure through Mar 2026 stood at $56528.0 (down 70.14% YoY), while the FY2025 annual figure was $60227.0, down 69.43% from the prior year.
- Current Deferred Revenue was $56528.0 for Q1 2026 at Bioregenx, down from $60227.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $629000.0 in Q4 2022 to a low of $56528.0 in Q1 2026.
- Historically, Current Deferred Revenue has averaged $218512.7 across 5 years, with a median of $189282.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue plunged 36.12% in 2025, then slumped 70.14% in 2026.
- A 5-year view of Current Deferred Revenue shows it stood at $629000.0 in 2022, then plunged by 43.69% to $354203.0 in 2023, then plunged by 44.38% to $197000.0 in 2024, then sank by 69.43% to $60227.0 in 2025, then slipped by 6.14% to $56528.0 in 2026.
- The last three Current Deferred Revenue figures came in at $56528.0 (Q1 2026), $60227.0 (Q4 2025), and $95775.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Bioregenx | - | - | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,528.00 |
| Dec 31, 2025 | 60,227.00 |
| Sep 30, 2025 | 95,775.00 |
| Jun 30, 2025 | 125,174.00 |
| Mar 31, 2025 | 189,282.00 |
| Dec 31, 2024 | 197,000.00 |
| Sep 30, 2024 | 165,574.00 |
| Jun 30, 2024 | 195,938.00 |
| Mar 31, 2024 | 334,939.00 |
| Dec 31, 2023 | 354,203.00 |
| Dec 31, 2022 | 629,000.00 |